Equities

Inspiration Healthcare Group PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Inspiration Healthcare Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)17.13
  • Today's Change0.125 / 0.74%
  • Shares traded57.05k
  • 1 Year change+20.18%
  • Beta1.0387
Data delayed at least 20 minutes, as of Feb 10 2026 13:35 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Inspiration Healthcare Group plc is a United Kingdom-based global medical technology company providing neonatal intensive care medical devices. The Company provides products to patients around the world which help to improve patient outcomes, whether it is a baby who has been born prematurely, or a patient undergoing surgery. Its areas of care include Acute Care and Infusion Therapies. Its Acute Care products include neonatal, respiratory, auto FiO2, obstetrics and developmental care. It offers a full range of ambulatory infusion pumps, administration sets, accessories, and patient infusion management systems for both hospital and homecare applications. It provides a range of Micrel Medical infusion devices, for various applications such as parenteral nutrition, oncology, immunoglobulin therapy, antibiotic infusion, palliative care, acute pain management, and obstetrics. It is also a manufacturer of specialist pneumatic oxygen-powered life support ventilators.

  • Revenue in GBP (TTM)45.20m
  • Net income in GBP-11.44m
  • Incorporated1998
  • Employees214.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Genincode PLC2.91m-4.97m3.30m36.00--1.24--1.13-0.0232-0.02320.01370.00930.656215.742.8780,944.45-111.87---164.53--53.02---170.49--2.73-10.960.0669--25.05--36.80------
Surgical Innovations Group Plc11.92m-1.44m4.20m88.00--0.4903--0.3523-0.0015-0.00150.01280.00920.93142.914.72135,397.70-11.22-7.76-14.17-9.6027.8929.97-12.04-11.660.95248.460.0987---0.57432.16-281.73---8.28--
Cambridge Nutritional Sciences PLC8.06m1.37m4.76m84.003.500.43052.380.59050.00570.00570.03380.04650.61533.593.5795,940.4810.42-3.2211.69-3.6766.4458.8516.94-7.213.79--0.021---14.77-3.23577.44---29.24--
Feedback plc885.62k-7.32m4.89m28.00--0.7925--5.52-0.2618-0.26180.03090.14070.1174--9.8331,629.29-96.97-38.54-105.98-41.6587.9290.05-826.25-435.27----0.00---25.0514.50-121.85---1.14--
Proteome Sciences plc4.53m-3.33m6.05m36.00------1.34-0.0113-0.01130.0153-0.02910.50875.925.75125,750.00-37.44-8.02----17.4345.80-73.60-15.070.0774-2.512.26---2.800.9731-39.42--31.03--
Rua Life Sciences PLC5.17m-850.00k9.00m33.00--1.26--1.74-0.0137-0.01370.08320.11510.54591.186.23---9.18---10.42--77.10---16.82--3.87--0.0995--------------
Genedrive PLC954.00k-5.23m10.81m43.00--4.56--11.33-0.0093-0.00930.00170.00230.1984--1.8022,186.05-108.81-77.52-153.92-106.30-----548.32-1,016.121.64--0.00--90.42-2.0726.06---10.48--
Verici DX PLC1.40m-5.56m10.91m15.00--0.9642--7.81-0.0229-0.02290.00580.00750.2298--1.6777,631.66-91.48---119.40--81.60---398.12------0.102--229.62--32.75------
Cellbxhealth PLC2.62m-15.78m11.96m119.00--0.2897--4.56-0.0489-0.04890.00810.03620.10280.59391.4622,050.42-61.80-41.90-72.78-46.8162.2718.55-601.37-1,051.132.63-470.570.2387--30.92--29.34------
Abingdon Health PLC8.43m-3.42m15.06m121.00--2.19--1.79-0.0176-0.01760.04350.02741.179.713.8769,661.16-47.42-54.04-70.70-85.9144.3230.37-40.51-110.071.58--0.1625--37.399.99-168.69---26.92--
Inspiration Healthcare Group PLC45.20m-11.44m15.24m214.00--0.9312--0.3372-0.1275-0.12750.50380.18261.032.005.91211,215.00-25.96-6.05-33.03-7.4544.3946.62-25.32-7.011.112.420.441--1.6516.56-148.04--39.05--
Renalytix PLC2.19m-14.90m25.20m45.00------11.50-0.0594-0.05940.008-0.01540.45477.644.54---309.18-83.70---107.2540.0028.27-680.00-1,519.311.17-24.576.38--31.06--55.14------
Aptamer Group PLC1.20m-2.42m25.62m31.00--13.69--21.30-0.0014-0.00140.00070.00070.42946.274.3538,806.45-86.53---154.00--48.13---201.50--1.48-84.630.2622--39.88--18.05------
Data as of Feb 10 2026. Currency figures normalised to Inspiration Healthcare Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

49.71%Per cent of shares held by top holders
HolderShares% Held
BGF Investment Management Ltd.as of 30 May 202518.87m21.04%
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Jan 20257.12m7.95%
Liontrust Investment Partners LLPas of 30 May 20254.14m4.62%
Octopus Investments Ltd.as of 30 Jun 20243.80m4.24%
Stonehage Fleming Investment Management Ltd.as of 30 Sep 20253.23m3.60%
Castlefield Investment Partners LLPas of 30 May 20252.95m3.29%
BlackRock Investment Management (UK) Ltd.as of 03 Nov 20252.18m2.43%
Hargreaves Lansdown Fund Managers Ltd.as of 03 Nov 2025799.00k0.89%
HSBC Global Asset Management (UK) Ltd.as of 03 Nov 2025765.00k0.85%
Premier Fund Managers Ltd.as of 31 Jul 2025724.08k0.81%
More ▼
Data from 31 Mar 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.